Now Available: Final Rule for FDAAA 801 and NIH Policy on Clinical Trial Reporting
441 studies found for:    multiple myeloma | thalidomide
Show Display Options
Rank Status Study
1 Completed Thalidomide for Multiple Myeloma
Condition: Multiple Myeloma
Intervention: Drug: Thalidomide
2 Completed Thalidomide 100 mg/Day Versus Thalidomide 400 mg/Day in Relapse Refractory Multiple Myeloma
Condition: Multiple Myeloma
Intervention: Drug: Thalidomide
3 Completed Pharmacokinetic Study of Thalidomide in Subjects With Multiple Myeloma
Condition: Multiple Myeloma
Intervention: Drug: Thalidomide Celgene™
4 Completed A Study of Combination Thalidomide Plus Dexamethasone Therapy vs. Dexamethasone Therapy Alone in Previously Untreated Subjects With Multiple Myeloma
Condition: Multiple Myeloma
Interventions: Drug: A (Thalidomide + Dexamethasone);   Drug: B (Placebo + Dexamethasone)
5 Completed Thalidomide to Patients With Previously Untreated Multiple Myeloma
Condition: Multiple Myeloma
Interventions: Drug: thalidomide;   Drug: placebo
6 Completed Thalidomide-Dexamethasone for Multiple Myeloma
Condition: Multiple Myeloma
Interventions: Drug: Thalidomide;   Drug: Dexamethasone
7 Completed
Has Results
Bortezomib and Thalidomide in Treating Patients With Newly Diagnosed Stage II or Stage III Multiple Myeloma
Condition: Multiple Myeloma
Interventions: Drug: bortezomib;   Drug: thalidomide
8 Completed Thalidomide Plus Dexamethasone as Maintenance Therapy for Multiple Myeloma
Condition: Multiple Myeloma
Interventions: Drug: Thalidomide plus dexamethasone;   Drug: Dexamethasone
9 Completed Anti-Angiogenesis Therapy Using Thalidomide in Multiple Myeloma
Condition: Multiple Myeloma
Intervention: Drug: Thalidomide
10 Terminated Comparison of Melphalan-Prednisone (MP) to MP Plus Thalidomide in the Treatment of Newly Diagnosed Very Elderly Patients (> 75 Years) With Multiple Myeloma
Condition: Newly Diagnosed, Multiple Myeloma
Interventions: Drug: Thalidomide;   Drug: melphalan, prednisone;   Drug: melphalan, prednisone, thalidomide
11 Completed Velcade, Melphalan, Prednisone And Thalidomide Versus Velcade, Melphalan, Prednisone in Multiple Myeloma Patients
Condition: Multiple Myeloma
Interventions: Drug: Bortezomib, Melphalan, Prednisone, Thalidomide;   Drug: Bortezomib, Melphalan, Prednisone
12 Recruiting Multicenter Clinical Trial to Investigate the Efficacy and Safety of Bendamustine, Dexamethasone and Thalidomide in Relapsed or Refractory Multiple Myeloma Patients After Treatment With Lenalidomide and Bortezomib or Which Are Ineligible to One of These Drugs
Condition: Multiple Myeloma
Intervention: Drug: Bendamustine + Dexamethasone + Thalidomide
13 Completed Thalidomide and Prednisone Following Peripheral Stem Cell Transplantation in Treating Patients With Multiple Myeloma
Condition: Multiple Myeloma and Plasma Cell Neoplasm
Interventions: Drug: prednisone;   Drug: thalidomide
14 Completed Melphalan, Prednisone, Thalidomide And Bortezomib In Advanced And Refractory Multiple Myeloma Patients
Condition: Multiple Myeloma
Interventions: Drug: THALIDOMIDE;   Drug: BORTEZOMIB
15 Completed Efficacy and Safety Study of 3 Thalidomide Doses for the Treatment of Relapsed Refractory Multiple Myeloma
Condition: Multiple Myeloma
Interventions: Drug: Thalidomide;   Drug: Dexamethasone
16 Unknown  Iberoamerican Protocol With Thalidomide in Patients With Symptomatic Newly Diagnosed Multiple Myeloma Over 65 Years
Condition: Multiple Myeloma
Interventions: Drug: Thalidomide, Cyclophosphamide, Dexamethasone;   Drug: Thalidomide, Dexamethasone;   Drug: Thalidomide, Melphalan, Prednisone
17 Terminated
Has Results
S0417 Bortezomib, Thalidomide, and Dexamethasone in Treating Patients With Relapsed or Refractory Multiple Myeloma
Condition: Multiple Myeloma
Interventions: Drug: bortezomib;   Drug: dexamethasone;   Drug: thalidomide
18 Completed RMPT for Relapsed/Refractory Multiple Myeloma
Condition: Multiple Myeloma
Intervention: Drug: Revlimid, Melphalan, Prednisone, Thalidomide
19 Active, not recruiting Auto-Allo Tandem Stem Cell Transplantation for Patients With Multiple Myeloma
Condition: Multiple Myeloma
Interventions: Procedure: Auto-Allo Tandem SCT and maintenance therapy with Thalidomide/ DLI;   Procedure: auto-auto Tandem stem cell transplantation and maintenance therapy with Thalidomide
20 Completed
Has Results
A Study to Evaluate Two Different Regimens of VELCADE in Combination With Dexamethasone, Thalidomide and Cyclophosphamide (VDT vs VDTC) in Newly Diagnosed Multiple Myeloma
Condition: Multiple Myeloma
Interventions: Drug: bortezomib, dexamethasone, and thalidomide;   Drug: bortezomib, dexamethasone, thalidomide, and cyclophosphamide

   Previous Page Studies Shown (1-20) Next Page (21-40) Show next page of results    Last Page
Study has passed its completion date and status has not been verified in more than two years.